5-Benzothiazolamine, 2-methyl- → HCID 25070100, compound

HRID 1666295Notes

Reaction equation

HRID 1666295 reaction equation
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[N:7]1[C:11]2=[N:12][CH:13]=[CH:14][CH:15]=[C:10]2[CH:9]=[C:8]1[C:16]([O:18]CC)=O.[NH2:21][C:22]1[CH:23]=[CH:24][C:25]2[S:29][C:28]([CH3:30])=[N:27][C:26]=2[CH:31]=1>>[CH3:30][C:28]1[S:29][C:25]2[CH:24]=[CH:23][C:22]([NH:21][C:16]([C:8]3[N:7]([C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=4)[C:11]4=[N:12][CH:13]=[CH:14][CH:15]=[C:10]4[CH:9]=3)=[O:18])=[CH:31][C:26]=2[N:27]=1

Participants

3

Reactant 2

HCID 362295-Benzothiazolamine, 2-methyl-HCID 67444397HCID 67444397, compound

Product 1

HCID 25070100HCID 25070100, compound

Procedure

This compound was prepared according to the experimental protocol described in Example 6.2, starting with ethyl 1-(2-pyridyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate obtained according to the protocol described in step 8.1 and 5-amino-2-methylbenzothiazole. A white solid is obtained.

Workup

  1. customThis compound was prepared
  2. customobtained
  3. customA white solid is obtained

Sources & evidence

ORD record
ord-ea5a339a18f34069bb188795356f9ece
Source dataset
uspto-grants-2011_10
Patent number
US08044066B2

Reaction notes

Loading…